Vedere

Developer of gene therapy for vision restoration

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups5 employees language vederebio.com

Registered entities

Investor mix

8 investors on record; lead investors include Octagon Capital Advisors, Atlas Venture.

Investor typeCountShare
Venture capital8100%
Coming soon